Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. RVPH
RVPH logo

RVPH News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

RVPH News

Reviva Pharmaceuticals Advances Schizophrenia Drug Development

Mar 30 2026Newsfilter

Reviva Pharmaceuticals Closes $10 Million Public Offering

Mar 24 2026NASDAQ.COM

Reviva Pharmaceuticals Raises Funds for Schizophrenia Trial

Mar 19 2026stocktwits

Reviva Pharmaceuticals Prices Public Offering at $1.50 per Share

Mar 19 2026NASDAQ.COM

Reviva Pharmaceuticals Shares Plunge 42% Following Proposed Public Offering

Mar 19 2026NASDAQ.COM

Reviva Pharmaceuticals Plans Public Offering of Stock and Warrants

Mar 18 2026seekingalpha

Reviva Pharmaceuticals CEO to Present at Neuroscience Innovation Forum in San Francisco

Dec 29 2025Globenewswire

Reviva Pharmaceuticals CEO to Present at 9th Annual Neuroscience Innovation Forum

Dec 29 2025Newsfilter

RVPH Events

No data

No data

RVPH Monitor News

Reviva Pharmaceuticals advances schizophrenia drug with new trial plans

Apr 02 2026

Reviva Pharmaceuticals Raises Funds for Schizophrenia Trial

Mar 19 2026

Reviva Pharmaceuticals stock drops amid FDA trial feedback

Dec 23 2025

RVPH Earnings Analysis

No Data

No Data

People Also Watch